Nordic Life Science 1
Salvador Aznar Benitah's discoveries on metastasi
s has led to the co-founding of ONA Therapeutics in 2019. were able to build a completely new city. That, in essence, is what a metastatic cell does. And to achieve this, it needs an enormous amount of energy. You wouldn’t take vegetables for a trip like that, but rather very energy-rich foods, especially fats and proteins. Fat, in fact, is the most efficient energy source.” STEM CELLS IN EUROPE A 64 | NORDICLIFESCIENCE.ORG znar Benitah and his team are investigating how to block these cells’ access to fat, thereby reducing their ability to colonize other tissues. Looking to the future, he is now focusing part of his research on understanding how organs and tissues coordinate systemically to maintain proper bodily physiology. His goal is to decipher how they communicate with each other, how they respond collectively to damage, and why this coordination is lost during aging and in diseases such as cancer. His discoveries on metastasis led to the co-founding of ONA Therapeutics in 2019, a company focused on developing treatments against metastatic cells. Recognized with numerous international scientific awards, his work continues to open new avenues for preventing disease and designing more effective therapies. NLS The European stem cell market is growing rapidly, with a projected value exceeding USD 9 billion by 2030, driven by a surge in regenerative medicine research and an aging population. In 2018, over 30 000 patients in the EU received healthy blood-forming cells (stem cells) to replace their own that had been destroyed. The highest numbers of stem cell transplants were reported in Germany (7,900), France (5 800), Italy (5,700) and Spain (3,400). The EU accounts for roughly one-quarter of worldwide cell therapy and regenerative medicine trials. Source: Grand View Horizon, Eurostat, NIH EUROPE // SCIENCE